Pragmatic Asthma Study Participant Identification Using Electronic Health Records
Explore the limitations and strategies of using electronic health records for participant identification in pragmatic asthma studies, focusing on disparities in asthma burden among minority populations like Blacks and Hispanics. The PREPARE study design, leveraging EHRs to identify at-risk adults for asthma exacerbations, is highlighted, along with the potential of EHR queries as a cost-effective method for participant identification. Learn about the importance of education in improving asthma control and the Patient-Activated Reliever-Triggered Inhaled CorticoSteroid approach in managing poorly controlled asthma among minority groups.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
Limitations of electronic health records in identifying study participants for pragmatic asthma studies Michelle L. Hernandez MD, Kathleen M. Mottus PhD, Michelle C Hayes BA, Jennifer Rees RN CPF CRN, Tamera Coyne-Beasley MD North Carolina Network Consortium North Carolina Translational and Clinical Sciences (NC TraCS) Institute June 24, 2019
Blacks and Hispanics have a disproportionately higher asthma burden (2007-2009) 3x more likely to be hospitalized 4.5x more likely to visit ED Higher mortality: 3x more likely to die from asthma-related causes CDC National Surveillance of Asthma: US, 2001-2010
Reasons for this disparity? Lack of education and/or understanding that controller meds need to be used even when symptoms NOT present PeRson EmPowered Asthma RElief (PREPARE) Study Pragmatic comparative effectiveness trial in Blacks & Hispanics with poorly controlled asthma on a daily inhaled corticosteroid (ICS) therapy Erick Forno; Published in: Juan C. Celed n; Am J Respir Crit Care Med 2012
PREPARE Study Design AA or H/L adults at risk for asthma exacerbations PARTICS + 15 Monthly Surveys 1 study visit: video consent , baseline data, inhaler video Or Standard of Care Primary Endpoint: Asthma exacerbations Treatment with systemic corticosteroid therapy Patient-Activated Reliever-Triggered Inhaled CorticoSteroid (PARTICS)
PREPARE identified participants using Electronic Health Records (EHRs) Queries of EHRs are being heavily leveraged as a potential cost-effective method for participant identification In previous studies using a minority population Blacks and Exacerbations on LABA v. Tiotropium (BELT)] (Wechsler et al, JAMA 2015) Study sites recruited ~14% of EHR-identified patients (1100/~8000) PREPARE study assumptions used the BELT EHR experience EHRs can identify patients taking the required medications Assume 80% of those identified will qualify when screened UNC Chapel Hill is one of 18 participating sites UNC s first pragmatic asthma clinical trial
4-Part Identification Strategy Potential Patients Identified (Data Warehouse) Step 1: Carolina Data Warehouse (CDW) submission Asthma in the problem list Ages 18-74 Alive Hispanic/Latino, Black/African-American Chart Review Made Contact Screened Patients Seen for asthma diagnosis in the past year On a daily ICS or ICS/LABA therapy Does not have another chronic lung disease other than asthma Scheduled and Enrolled
4-Part Identification Strategy Potential Patients Identified (Data Warehouse) Step 2: CDW refinement From CDW identified patients: Review from clinics whose providers have agreed to have their patients contacted & Who reviewed the Asthma IQ guidelines Chart Review Made Contact 1038 patients Screened Patients Time? Processing Data Warehouse 3 hours per quarter Scheduled and Enrolled
4-Part Identification Strategy Potential Patients Identified (Data Warehouse) Step 3 Review the EHR (clinical notes, med list, & PFTs) Confirm current medication PFT values ACT scores 1038 Patients Chart Review 479 eligible after chart review 46% sensitivity Made Contact Screened Patients Time? 30 minutes/chart x 1038 charts 239 hours to identify eligible participants 288 hours to exclude ineligible participants Scheduled and Enrolled
4-Part Identification Strategy Potential Patients Identified (Data Warehouse) Step 4 Contact potential participants Review recent exacerbations & updated ACT 411 eligible after phone screen Sensitivity: 39.5% Chart Review Made Contact Time? Screened Patients 30 minutes/phone call x 479 205 hours to identify eligible participants 34 hours to exclude ineligible participants Scheduled and Enrolled Time? Study visit: 2 hours
Phone Interview for Pre-Eligible Study Participants Chart Review 18-75 years of age? Yes Yes Yes No No No Asthma Diagnosis >1 year Latino ancestry and/or African American? Currently prescribed ICS as daily maintenance therapy? Airduo Respiclick Advair HFA or Advair Diskus Symbicort Breo Dulera QVAR Aerospan Alvesco ArmonAir Flovent Diskus or Flovent MDI Asmanex Twisthaler Arnuity Elllipta Pulmicort Flexhaler Currenty prescribed rescue? Proventil ProAir HFA/ProAir RespiClick Ventolin Xopenex Atrovent Combivent Yes No Yes No Yes No No Yes Date: __________ No N/A N/A COPD, Chronic bronchitis, emphysema or another chronic lung disease? Yes Yes Meets COPD Inclusion Checklist Meets Biologic Checklist for Inclusion In the past 4 weeks, taken steroid pills or shots, like prednisone, or been to the emergency room or urgent care, or been in the hospital overnight for problems with your asthma? No Yes No In the past 6 months, had a lung procedure called bronchial thermoplasty? Currently prescribed oral steroids like prednisone every day or every other day for asthma or any other medical problem? In the past year, have you taken steroid pills or shots, like prednisone, or been to the Emergency Room or urgent care, or been in the hospital overnight for problems with your asthma? Yes No Yes No ACT Not Needed ACT Needed
Most commonly identified reasons for ineligibility Other(>9) Biologic No asthma visit last year Vanguard Other health concern Chronic Lung Disease Unable to follow instructions 17% On oral steroids 10% 7% No rescue Med Language 10% No asthma DX 348 patients medications were not correctly captured 51.5% of ineligible participants 35% No ICS
Conclusions Our EHR had low sensitivityfor identifying participants for a pragmatic asthma clinical trial UNC PREPARE: 46% qualified after chart review; 39.5% after phone screen Significant research coordinator time spent reviewing EHRs from ineligible participants Based on data input to the data warehouse BELT study: 80% qualified after screen EHR use intended to promote cost savings for pragmatic trials 322 hours of coordinator time on excluding ineligible participants UNC one of 18 sites Will need to investigate EHR performance characteristics at other study sites
Conclusions Reasons? Current problem list/medications not updated regularly by providers/clinical staff Time problem! Heterogeneity in asthma care among providers & patient education More complexity to inclusion criteria than other asthma trials Distinction between daily OCS v. exacerbations Change in inclusion criteria
Conclusions Lessons learned Prior to study start, identify parameters for the best computable phenotype Proper balance of sensitivity & specificity Allocate budgeted time EHR data analysts to refine computable phenotype Still need research coordinators to review charts Goal Better estimate of cost/patient enrolled Increased willingness to participate in pragmatic trials Improved patient outcomes
